Notably, the occurrence of bullous pemphigoid was observed in cancer patients treated sequentially with PD-1 and CTLA-4, but not in those treated with ipilimumab monotherapy [269,279]. This evidence concerns the gene PDCD1 and bullous pemphigoid.